. 2021 Dec 9;11(1):e210020. doi: 10.1530/ETJ-21-0020
This work is licensed under a Table 1.
Clinicopathological Features of DSV-PTV at diagnosis.
| Variables | |
|---|---|
| Sex, n (%) | |
| Female | 26 (78.8) |
| Male | 7 (21.2) |
| Age (years), x ± s, min–máx | 29.4 ± 11.7, 10–65 |
| Positive TPO antibodies (n = 11), n (%) | 6 (66.7) |
| Positive anti-Tg antibodies (n = 33), n (%) | 14 (42.4) |
| Hypothyroidism (n = 33), n (%) | 3 (9.1) |
| Palpable goiter/adenopathy (n = 29), n (%) | 28 (84.8) |
| Goiter | 20 (60.6) |
| Adenopathy | 8 (24.2) |
| Previous cytological data suspicious/diagnostic of malignancy (n = 21), n (%) | 21 (100) |
| Bilaterality (n = 33), n (%) | 24 (72.7) |
| Diffuse pattern (uni/bi) (n = 33), n (%) | 22 (71.4) (2/20) |
| Extrathyroidal extension (n = 29), n (%) | 15 (51.7) |
| Lymphovascular invasion (n = 29), n (%) | 14 (48.3) |
| Psammomatous bodies (n = 29), n (%) | 9 (27.6) |
| Lymphocytic infiltrate (n = 29), n (%) | 14 (48.3) |
| Thyroid capsular invasion (n = 29), n (%) | 19 (65.5) |
| TNM staging (n = 33), n (%) | |
| T1a/1b | 1 (3.0)/0 (0) |
| T2 | 7 (21.2) |
| T3 | 14 (42.4) |
| T4a/4b | 4 (12.1)/1 (3.0) |
| Tx | 6 (18.2) |
| N0 | 6 (18.2) |
| N1a/1b | 7 (21.2)/20 (60.6) |
| Number of resected lymph nodes per patient, Med (Q1;Q3), min–máx (n = 26) | 16.5 (1.5; 46), 0–74 |
| Number of total metastatic lymph nodes per patient, Med (Q1;Q3), min–máx (n = 26) | 9.5 (0; 16.8), 0–45 |
anti-Tg, antithyroglobulin; Bi, bilateral; Uni, unilateral.